News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResApp Health.
RELATED STOCKHEAD STORIES
Health & Biotech
ResApp plummets after follow-up coughing app trial disappoints investors
Health & Biotech
Expert view: why it’s a critical time for investment in ASX small cap health stocks
Health & Biotech
Check Up: here’s what’s happening with 140 ASX small cap health stocks
Tech
Artificial Intelligence will be used in 70pc of businesses by 2030: McKinsey
News
Lunchtime ASX small cap wrap: who’s popping corks today
Health & Biotech
US fighter pilots will cough into an Aussie smartphone app to see if they’re fit to fly
Health & Biotech
ResApp releases sleep apnoea news – but only after tap on the shoulder from ASX
Health & Biotech
ResApp kicks off coughing app retrial, hasn’t forgotten horrifying first attempt
Health & Biotech
Will Artificial Intelligence help health-tech stocks find their bounce?
Health & Biotech
Top tips for investing in ASX-listed digital health stocks
Health & Biotech
Medecins Sans Frontieres backs out of ResApp coughing app trial
Health & Biotech
Cough app maker ResApp soars 48pc after confirming new US trial
Health & Biotech
ResApp gets a boost from appointment of new science advisor
News
POP is top, RAP is not: last week’s small cap winners and losers
Health & Biotech